109144 ⎘
Structure or type of the nucleic acid; Type of nucleic acid Decoys
OLIGONUCLEOTIDES FOR THE TREATMENT OF BREAST CANCER
#2Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription
#3Methods and Compositions for RNA-Directed Target DNA Modification and for RNA-Directed Modulation of Transcription
#4Retroelement-generated transcription factor decoys
#5Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription
#6CHIMERIC COMPLEX AND THERAPEUTIC USES THEREOF
#7BC200 RNA DECOY COMPOUNDS AND METHODS OF USE FOR THE TREATMENT OF AUTOIMMUNE DISEASES, INCLUDING LUPUS
#8OLIGONUCLEOTIDE FOR INHIBITING QUAKING ACTIVITY
#9CTLA-4 APTAMER CONJUGATES
#10METHOD FOR MODULATING UNPRODUCTIVE ALTERNATIVE SPLICING
#11ORAL DELIVERY OF OLIGONUCLEOTIDES
#12Noninvasive AAV Vectors For Highly Efficient Gene Delivery To The Nervous System
#13Treatment of Genetic Dilated Cardiomyopathies
#14METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR DISEASES
#15METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#16METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA DIRECTED MODULATION OF TRANSCRIPTION
#17Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#18Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#19Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#20Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#21USE OF CD9 AS A BIOMARKER AND AS A BIOTARGET IN GLOMERULONEPHRITIS OR GLOMERULOSCLEROSIS
#22CTLA-4 aptamer conjugates
#23A DBAIT MOLECULE IN COMBINATION WITH KINASE INHIBITOR FOR THE TREATMENT OF CANCER
#24METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#25METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#26METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#27METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#28METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#29METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#30USE OF MIR-204 INHIBITOR TO INCREASE NURR1 PROTEIN EXPRESSION
#31METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#32Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#33Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#34Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#35OLIGONUCLEOTIDE INHIBITORS OF NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS AND THE USES THEREOF
#36Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#37Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#38Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#39Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#40Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#41METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#42Transcription Factor Trapping by RNA in Gene Regulatory Elements
#43OLIGONUCLEOTIDE-BASED PROTEOLYSIS TARGETING CHIMERA
#44MICRORNA INHIBITORS FOR USE IN TREATING METABOLIC DISEASES
#45Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#46Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#47Peptide docking vehicle for targeted nucleic acid delivery
#48Isolation of novel AAV's and uses thereof
#49METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC AND METABOLIC DISEASES
#50Cancer chemoprevention with STAT3 blockers
#51Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#52Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#53Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#54NFAT binding polynucleotides
#55Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#56Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#57Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#58Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#59TREATMENT OF CANCER BY SYSTEMIC ADMINISTRATION OF DBAIT MOLECULES
#60CTLA-4 aptamer conjugates
#61Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#62Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#63Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#64Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#65METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#66METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#67METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#68METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#69Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#70Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#71METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#72Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#73Use of a combination of Dbait molecule and PARP inhibitors to treat cancer
#74Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#75METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#76Regulation of MIR-143 using nucleic acid molecules
#77CHIMERIC RNA OLIGONUCLEOTIDES AND USES THEREOF
#78COMPOSITIONS AND METHODS FOR PAIN AMELIORATION VIA MODIFICATION OF GENE EXPRESSION
#79Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#80Nucleic Acid Complexes
#81Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#82Isolation of novel AAV's and uses thereof
#83Oligonucleotide decoys for the treatment of pain
#84Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#85Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#86Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#87Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#88Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#89Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#90Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#91Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#92Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#93METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#94METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#95METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#96METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#97Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#98Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#99Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#100Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription
#101Glycosylated oligonucleotides that mimic the HIV-1 epitope of neutralizing monoclonal antibody 2G12
#102Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#103Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#104Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#105Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#106Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#107Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#108Treatment of cancer by systemic administration of Dbait molecules
#109METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#110Transcription Factor Trapping by RNA in Gene Regulatory Elements
#111Methods and pharmaceutical compositions for the treatment of filovirus infections
#112TLX and MIR-219 as potential therapeutic targets for neurodevelopmental disorders
#113METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#114METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#115METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#116METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#117Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#118Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#119Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#120STAT3 inhibitors and uses thereof
#121METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#122METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#123Chimeric decoy
#124Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#125METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#126METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#127METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#128METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#129METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#130Antisense oligonucleotide compositions
#131Compositions and Methods for Inducing Senescence in Cancer Cells
#132METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#133METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#134Stabilization method of functional nucleic acid
#135METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#136METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#137METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#138METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#139Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#140Stabilized STAT3 decoy oligonucleotides and uses therefor
#141EFFECTS OF APOLIPOPROTEIN B INHIBITION ON GENE EXPRESSION PROFILES IN ANIMALS
#142Methods and pharmaceutical compositions for the treatment of filovirus infections
#143Treatment of facioscapulohumeral dystrophy
#144Nucleic acid complexes
#145Decoy oligonucleotides for the treatment of diseases
#146DOWNREGULATION OF SINE/ALU RETROTRANSPOSON TRANSCRIPTION TO INDUCE OR RESTORE PROLIFERATIVE CAPACITY AND/OR PLURIPOTENCY TO A STEM CELL
#147Oligonucleotide decoys for the treatment of pain
#148NUCLEIC ACIDS ACTING AS DECOYS FOR THE TREATMENT OF LENTIVIRUS INFECTION
#149Isolation of novel AAV's and uses thereof
#150Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#151Isolation of novel AAV's and uses thereof
#152Compositions and methods for treating cancer, inhibiting cell proliferation, and inducing cell death
#153Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#154STAT3 inhibitors and uses thereof
#155ANTI-VIRAL THERAPY
#156RNA-BASED HIV INHIBITORS
#157Gene expression and pain
#158Compositions and Methods for Inducing Senescence in Cancer Cells
#159Antisense oligonucleotide compositions
#160Block Decoys
#161Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#162Isolation of novel AAV's and uses thereof
#163Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#164Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#165COMPOSITION FOR EXTERNAL APPLICATION COMPRISING TRANSCRIPTION FACTOR DECOY AS ACTIVE INGREDIENT
#166CTLA-4 aptamer siRNA species
#167Nucleic acid complexes
#168Composition and Method for In Vivo and In Vitro Attenuation of Gene Expression Using Double Stranded RNA
#169Oligonucleotide, glucocorticoid sensitivity enhancer, pharmaceutical composition, and expression vector
#170Small activating RNA molecules and methods of use
#171Gene expression and pain
#172Stabilized STAT3 decoy oligonucleotides and uses therefore
#173Methods and compositions for gene-specific demethylation by DNA methyltransferase (DNMT)-RNA interaction
#174Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
#175Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#176Transcription factor decoys
#177Application of highly conserved domain sequences from viral genome as template to design therapeutic sliRNAs
#178Constructs and methods for the assembly of biological pathways
#179Nucleic acid complexes
#180Stabilized STAT3 decoy oligonucleotides and uses therefor
#181Modulation of eIF4E expression
#182Polyamides for nucleic acid delivery
#183Amphiphilic nucleotide cochleate compositions and methods of using the same
#184Gene expression and pain
#185Application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas
#186COMPOSITE POLYNUCLEIC ACID THERAPEUTICS
#187STABILIZATION METHOD OF FUNCTIONAL NUCLEIC ACID
#188TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-ALPHA2
#189Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription
#190METHODS FOR PRODUCTION AND USES OF MULTIPOTENT ,PLURIPOTENT, DIFFERENTIATED AND DISEASE-RESISTANT CELL POPULATIONS
#191Nucleic acid ligand complexes
#192Inhibition of HRP-3 using modified oligonucleotides
#193Polyamides for nucleic acid delivery
#194Inhibition of Tumor Growth via Peroxiredoxin 3
#195Gene expression and pain
#196SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION
#197Composition for external application comprising transcription factor decoy as active ingredient
#198Transcription factor decoys and use thereof
#199Decoy-containing pharmaceutical compositions and method of using the same
#200EFFECTS OF APOLIPOPROTEIN B INHIBITION ON GENE EXPRESSION PROFILES IN ANIMALS
#201Nucleic acid sequences comprising NF-κB binding site within O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter region and uses thereof for the treatment of cancer and immune-related disorders
#202AGENT FOR REGULATING BONE FORMATION
#203IMMUNOTHERAPY COMPOSITIONS, METHOD OF MAKING AND METHOD OF USE THEREOF
#204Treatment of cancer using TLR3 agonists
#205Small activating RNA molecules and methods of use
#206Isolation of novel AAV'S and uses thereof
#207AMPHIPHILIC NUCLEOTIDE COCHLEATE COMPOSITIONS AND METHODS OF USING THE SAME
#208Novel Oligonucleotide and NF-kB Decoy Comprising the Same
#209Methods and compositions for inhibition of viral replication
#210MODULATION OF eIF4E EXPRESSION
#211THERAPEUTIC AGENT FOR PERIODONTAL DISEASE AND ALVEOLAR BONE LOSS DUE TO SURGERY
#212Production of functional proteins: balance of shear stress and gravity
#213Platelet derived growth factor (PDGF) nucleic acid ligand complexes
#214Dbait and standalone uses thereof
#215Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
#216Method for the modulation of function of transcription factors
#217TRANSCRIPTION FACTOR DECOY OLIGODEOXYNUCLEOTIDES HAVING MULTIPLE CIS ELEMENTS
#218Modulation of the Transcription of Pro-Inflammatory Gene Products
#219Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
#220Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension
#221INHIBITION STAT-1
#222Polyamides for nucleic acid delivery
#223Modulation of eIF4E expression
#224Nucleic acid compositions and methods of introducing nucleic acids into cells
#225Methods and compositions for inhibition of viral replication
#226DBAIT and uses thereof
#227Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
#228Transcription factor decoy
#229Methods and compositions for silencing genes without inducing toxicity
#230High Affinity Nucleic Acid Ligands To Lectins
#231Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA)
#232Pharmaceutical composition containing decoy and method of using the same
#233Polyamides for nucleic acid delivery
#234Oligonucleotide decoys and methods of use
#235Therapeutic molecules for modulating stability of vegf
#236Decoy Nucleic Acid to Synoviolin Gene Promoter
#237Method for maintaining pluripotency of stem/progenitor cells
#238DECOY-OLIGNUCLEOTIDE INHIBITION OF CD40-EXPRESSION
#239Treatment of Cancer Using Tlr3 Agonists
#240Agent for Regulating Bone Formation
#241Gene expression and pain
#242MODULATION OF THE EXPRESSION OF STAT-1-DEPENDENT GENES
#243TREATMENT OF CANCER USING TLR3 AGONISTS
#244Chimeric Transcription Factor Decoy Oligonucleotides
#245Circular DNA vectors for synthesis of RNA and DNA
#246Modulation of Wrn-Mediated Telomere-Initiated Cell Signaling
#247Platelet derived growth factor (PDGF) nucleic acid ligand complexes
#248Decoy compositions for treating and preventing brain diseases and disorders
#249Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies
#250Target Nucleic Acid Of Retrovirus Integration
#251Small synthetic RNA, a method of preparing the same and uses thereof
#252Transition state analog inhibitors of ricin A-chain
#253Chimera (double) decoy
#254Modulation of innate immunity receptors' signaling by microRNAs miR-146a and miR-146b
#255Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
#256Nucleic acids useful for triggering tumor cell lethality
#257METHODS OF TREATING AND MONITORING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS
#258Decoy-containing pharmaceutical compositions and method of using the same
#259Dbait and uses thereof
#260Regulation of expression of high-affinity immunoglobulin E (IgE) receptor β-chain
#261NF-kB oligonucleotide decoy molecules
#262Modulation of eIF4E expression
#263Method for the modulation of function of transcription factors
#264Methods and compositions for silencing genes without inducing toxicity
#265Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies
#266Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#267Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
#268NF-kappaB oligonucleotide decoy molecules
#269STAT3 decoy oligonucleotides and uses therefor
#270Decoy-oligonucleotide-inhibition of cd40-expression
#271Pharmaceutical composition containing decoy and use of the same
#272Transforming growth factor-beta response element decoys and methods
#273Composite polynucleic acid therapeutics
#274Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR
#275Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc
#276Decoy compositions for treating and preventing brain diseases and disorders
#277Production of functional proteins: balance of shear stress and gravity
#278Functional correction of the C/T-variance of the human eNOS-gene
#279Remedy and preventive for diseases caused by NF-kB
#280Treatment of cancer using TLR3 agonists
#281Tenascin-C nucleic acid ligands
#282Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
#283High affinity TGFbeta nucleic acid ligands and inhibitors
#284Delivery of polynucleotides
#285Effects of apolipoprotein B inhibition on gene expression profiles in animals
#286RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA
#287Immunotherapy compositions, method of making and method of use thereof
#288Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA)
#289Decoy for treating and/or preventing th2 cytokine-associated allergic disease, gata3 mutant protein and medicinal compositions containing the same
#290HIF oligonucleotide decoy molecules
#291Modulation of expression of STAT-1 dependent genes
#292NF-kappaB oligonucleotide decoy molecules
#293RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
#294Nucleic acid ligand complexes
#295E2F oligonucleotide decoy molecules
#296Tissue adhesion formation control
#297Nucleic acid compositions and methods of introducing nucleic acids into cells
#298Truncation SELEX method
#299Thioaptamers enable discovery of physiological pathways and new therapeutic strategies
#300Sp1 and Sp3 targeted cancer therapies and therapeutics